Cargando…

Impact of reducing day 1 dexamethasone dose in anthracycline-containing regimens on acute gastrointestinal symptoms associated with breast cancer treatment

The potential of steroid sparing from day 2 onward is reported in anthracycline-containing regimens for breast cancer treatment. We evaluated whether the reduction of dexamethasone (DEX) dose from 9.9 to 6.6 mg on day 1 is possible in anthracycline-containing treatments. Patients receiving anthracyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saito, Yoshitaka, Takekuma, Yoh, Takeshita, Takashi, Sugawara, Mitsuru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640031/ https://www.ncbi.nlm.nih.gov/pubmed/34857855 http://dx.doi.org/10.1038/s41598-021-02765-3

Ejemplares similares

Impact of systemic dexamethasone administration on oral mucositis induced by anthracycline-containing regimens in breast cancer treatment
por: Saito, Yoshitaka, et al.
Publicado: (2022)

High dose of dexamethasone attenuates docetaxel-induced fluid retention in breast cancer treatment
por: Saito, Yoshitaka, et al.
Publicado: (2023)

Impact of systemic dexamethasone dosage on docetaxel-induced oral mucositis in patients with breast cancer
por: Saito, Yoshitaka, et al.
Publicado: (2023)

Severe Hypertriglyceridemia Induced by Docetaxel: A Novel Case Report
por: Saito, Yoshitaka, et al.
Publicado: (2021)

Adding aprepitant to palonosetron does not decrease carboplatin-induced nausea and vomiting in patients with gynecologic cancer
por: Watanabe, Yuko, et al.
Publicado: (2021)

Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report
por: Saito, Yoshitaka, et al.
Publicado: (2021)

Combination of Mirogabalin and Duloxetine Attenuates Peripheral Neuropathy by Eribulin: A Novel Case Report
por: Saito, Yoshitaka, et al.
Publicado: (2022)

Hypertriglyceridemia Induced by Fluorouracil: A Novel Case Report
por: Saito, Yoshitaka, et al.
Publicado: (2021)

Alleviation of Abdominal Pain due to Irinotecan-Induced Cholinergic Syndrome Using Loperamide: A Case Report
por: Uchiyama, Kazuki, et al.
Publicado: (2021)

Temporary Severe Neutropenia during Administration of Atezolizumab: A Novel Case Report
por: Kanno, Ryota, et al.
Publicado: (2023)

Pharmacokinetics and dose adjustment of etoposide administered in a medium-dose etoposide, cyclophosphamide and total body irradiation regimen before allogeneic hematopoietic stem cell transplantation
por: Tazawa, Yuki, et al.
Publicado: (2016)

Serotonin Syndrome Developing Immediately after the Initiation of Low-Dose Methadone Therapy: A Case Report
por: Kumai, Masayoshi, et al.
Publicado: (2020)

Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens
por: Kubota, Kaoru, et al.
Publicado: (2016)

Diabetes mellitus degenerates cisplatin-induced nephrotoxicity in short hydration method: a propensity score-matching analysis
por: Saito, Yoshitaka, et al.
Publicado: (2022)

An imaging approach for determining the mechanism of enhancement of intestinal absorption of an L-theanine supplement
por: Sato, Yuki, et al.
Publicado: (2021)

Onset timing and duration of augmented renal clearance in a mixed intensive care unit
por: Mikami, Ryusei, et al.
Publicado: (2023)

Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatment
por: Saito, Yoshitaka, et al.
Publicado: (2023)

The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas
por: Briski, R, et al.
Publicado: (2014)

Additional effect of anthracycline in preoperative chemotherapy with a sequential anthracycline‑containing regimen preceded by pertuzumab, trastuzumab and docetaxel combination therapy
por: Shima, Hiroaki, et al.
Publicado: (2022)

Improvement of renal function estimation equations for elderly Japanese people
por: Kaburaki, Soyoko, et al.
Publicado: (2018)

Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims database
por: Imai, Shungo, et al.
Publicado: (2020)

Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients
por: Saito, Yoshitaka, et al.
Publicado: (2023)

Validation of the usefulness of artificial neural networks for risk prediction of adverse drug reactions used for individual patients in clinical practice
por: Imai, Shungo, et al.
Publicado: (2020)

Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study
por: Kadomura, Shota, et al.
Publicado: (2019)

Prediction and Implications of Edoxaban-Associated Bleeding in Patients after Critical Illness
por: Mikami, Ryusei, et al.
Publicado: (2023)

Anthracycline dose and liver dysfunction
por: Cannizzaro, R, et al.
Publicado: (1999)

Cardiotoxicity by Anthracycline Regimen Chemotherapy Prolonged T Peak to T End Interval
por: Iqbal, Mohammad, et al.
Publicado: (2020)

Weekly taxane–anthracycline combination regimen versus tri-weekly anthracycline-based regimen for the treatment of locally advanced breast cancer: a randomized controlled trial
por: Tan, Qiu-Wen, et al.
Publicado: (2017)

Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and Cyclophosphamide
por: Suehiro, Marii, et al.
Publicado: (2021)

Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer
por: Susini, Tommaso, et al.
Publicado: (2014)

The comparison of anthracycline-based and non-anthracycline-based regimens in adjuvant chemotherapy of HER2-positive non-metastatic breast cancers
por: Najafi, Safa, et al.
Publicado: (2018)

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen
por: Giacchetti, S, et al.
Publicado: (2014)

Comparing low-dose (DART) and enhanced low-dose dexamethasone regimens in preterm infants with bronchopulmonary dysplasia
por: Al-taweel, Heba Mohamed, et al.
Publicado: (2023)

HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients
por: Del Mastro, L, et al.
Publicado: (2005)

Neutrophil-guided dosing of anthracycline–cyclophosphamide-containing chemotherapy in patients with breast cancer: a feasibility study
por: Drooger, Jan C., et al.
Publicado: (2015)

Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens
por: Yersal, Özlem, et al.
Publicado: (2018)

Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy
por: Kosaka, Yoshimasa, et al.
Publicado: (2015)

Near-Fatal Gastrointestinal Hemorrhage in a Child with Medulloblastoma on High Dose Dexamethasone
por: Yecies, Derek, et al.
Publicado: (2017)

Gastrointestinal Safety of Aspirin for a High-Dose, Multiple-Day Treatment Regimen: A Meta-Analysis of Three Randomized Controlled Trials
por: Forder, Samantha, et al.
Publicado: (2016)

Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens
por: de Vries Schultink, Aurelia H. M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qc52fao0kgo1u7fq72vgkp7kcc